138 related articles for article (PubMed ID: 35385341)
1. Type 2 immune polarization is associated with cardiopulmonary disease in preterm infants.
Lao JC; Bui CB; Pang MA; Cho SX; Rudloff I; Elgass K; Schröder J; Maksimenko A; Mangan NE; Starkey MR; Skuza EM; Sun YBY; Beker F; Collins CL; Kamlin OF; König K; Malhotra A; Tan K; Theda C; Young MJ; McLean CA; Wilson NJ; Sehgal A; Hansbro PM; Pearson JT; Polo JM; Veldman A; Berger PJ; Nold-Petry CA; Nold MF
Sci Transl Med; 2022 Apr; 14(639):eaaz8454. PubMed ID: 35385341
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 receptor antagonist prevents murine bronchopulmonary dysplasia induced by perinatal inflammation and hyperoxia.
Nold MF; Mangan NE; Rudloff I; Cho SX; Shariatian N; Samarasinghe TD; Skuza EM; Pedersen J; Veldman A; Berger PJ; Nold-Petry CA
Proc Natl Acad Sci U S A; 2013 Aug; 110(35):14384-9. PubMed ID: 23946428
[TBL] [Abstract][Full Text] [Related]
3. Pulmonary hypertension associated with bronchopulmonary dysplasia in preterm infants.
Bui CB; Pang MA; Sehgal A; Theda C; Lao JC; Berger PJ; Nold MF; Nold-Petry CA
J Reprod Immunol; 2017 Nov; 124():21-29. PubMed ID: 29035757
[TBL] [Abstract][Full Text] [Related]
4. Elevation of interleukin-8 and interleukin-6 precedes the influx of neutrophils in tracheal aspirates from preterm infants who develop bronchopulmonary dysplasia.
Munshi UK; Niu JO; Siddiq MM; Parton LA
Pediatr Pulmonol; 1997 Nov; 24(5):331-6. PubMed ID: 9407566
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-1 Receptor Antagonist Protects Newborn Mice Against Pulmonary Hypertension.
Bui CB; Kolodziej M; Lamanna E; Elgass K; Sehgal A; Rudloff I; Schwenke DO; Tsuchimochi H; Kroon MAGM; Cho SX; Maksimenko A; Cholewa M; Berger PJ; Young MJ; Bourke JE; Pearson JT; Nold MF; Nold-Petry CA
Front Immunol; 2019; 10():1480. PubMed ID: 31354700
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of inflammatory lung injury in the neonate: lessons from a transgenic mouse model of bronchopulmonary dysplasia.
Bry K; Hogmalm A; Bäckström E
Semin Perinatol; 2010 Jun; 34(3):211-21. PubMed ID: 20494738
[TBL] [Abstract][Full Text] [Related]
7. Refining anti-inflammatory therapy strategies for bronchopulmonary dysplasia.
Rudloff I; Cho SX; Bui CB; McLean C; Veldman A; Berger PJ; Nold MF; Nold-Petry CA
J Cell Mol Med; 2017 Jun; 21(6):1128-1138. PubMed ID: 27957795
[TBL] [Abstract][Full Text] [Related]
8. Inhalation or instillation of steroids for the prevention of bronchopulmonary dysplasia.
Bassler D
Neonatology; 2015; 107(4):358-9. PubMed ID: 26044104
[TBL] [Abstract][Full Text] [Related]
9. Preterm cord blood CD4⁺ T cells exhibit increased IL-6 production in chorioamnionitis and decreased CD4⁺ T cells in bronchopulmonary dysplasia.
Misra R; Shah S; Fowell D; Wang H; Scheible K; Misra S; Huyck H; Wyman C; Ryan RM; Reynolds AM; Mariani T; Katzman PJ; Pryhuber GS
Hum Immunol; 2015 May; 76(5):329-338. PubMed ID: 25797206
[TBL] [Abstract][Full Text] [Related]
10. Inflammatory markers in intrauterine and fetal blood and cerebrospinal fluid compartments are associated with adverse pulmonary and neurologic outcomes in preterm infants.
Viscardi RM; Muhumuza CK; Rodriguez A; Fairchild KD; Sun CC; Gross GW; Campbell AB; Wilson PD; Hester L; Hasday JD
Pediatr Res; 2004 Jun; 55(6):1009-17. PubMed ID: 15155869
[TBL] [Abstract][Full Text] [Related]
11. Early pulmonary vascular disease in preterm infants at risk for bronchopulmonary dysplasia.
Mourani PM; Sontag MK; Younoszai A; Miller JI; Kinsella JP; Baker CD; Poindexter BB; Ingram DA; Abman SH
Am J Respir Crit Care Med; 2015 Jan; 191(1):87-95. PubMed ID: 25389562
[TBL] [Abstract][Full Text] [Related]
12. [Changes of serum interleukin-33 in preterm infants with bronchopulmonary dysplasia].
Chen JL; Zhang CL
Zhongguo Dang Dai Er Ke Za Zhi; 2020 Jul; 22(7):716-720. PubMed ID: 32669167
[TBL] [Abstract][Full Text] [Related]
13. Inflammatory cytokines in gastric fluid at birth and the development of bronchopulmonary dysplasia.
Stichel H; Bäckström E; Hafström O; Nilsson S; Lappalainen U; Bry K
Acta Paediatr; 2011 Sep; 100(9):1206-12. PubMed ID: 21438921
[TBL] [Abstract][Full Text] [Related]
14. Pulmonary dendritic cells in lungs of preterm infants: neglected participants in bronchopulmonary dysplasia?
De Paepe ME; Hanley LC; Lacourse Z; Pasquariello T; Mao Q
Pediatr Dev Pathol; 2011; 14(1):20-7. PubMed ID: 20050784
[TBL] [Abstract][Full Text] [Related]
15. Serial changes in levels of IL-6 and IL-1beta in premature infants at risk for bronchopulmonary dysplasia.
Kazzi SN; Romero R; McLaughlin K; Ager J; Janisse J
Pediatr Pulmonol; 2001 Mar; 31(3):220-6. PubMed ID: 11276135
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 balance in the lungs of preterm infants who develop bronchopulmonary dysplasia.
Kakkera DK; Siddiq MM; Parton LA
Biol Neonate; 2005; 87(2):82-90. PubMed ID: 15539764
[TBL] [Abstract][Full Text] [Related]
17. Maternal IL-1beta production prevents lung injury in a mouse model of bronchopulmonary dysplasia.
Bäckström E; Lappalainen U; Bry K
Am J Respir Cell Mol Biol; 2010 Feb; 42(2):149-60. PubMed ID: 19411613
[TBL] [Abstract][Full Text] [Related]
18. Natural History of Postnatal Cardiopulmonary Adaptation in Infants Born Extremely Preterm and Risk for Death or Bronchopulmonary Dysplasia.
Mirza H; Garcia JA; Crawford E; Pepe J; Zussman M; Wadhawan R; Oh W
J Pediatr; 2018 Jul; 198():187-193.e1. PubMed ID: 29625730
[TBL] [Abstract][Full Text] [Related]
19. Contribution of inflammation to lung injury and development.
Kallapur SG; Jobe AH
Arch Dis Child Fetal Neonatal Ed; 2006 Mar; 91(2):F132-5. PubMed ID: 16492951
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor levels and bronchopulmonary dysplasia in preterm infants.
Mariduena J; Ramagopal M; Hiatt M; Chandra S; Laumbach R; Hegyi T
J Matern Fetal Neonatal Med; 2022 Apr; 35(8):1517-1522. PubMed ID: 32366142
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
